Crossmark

The association of prescriber prominence in a shared-patient physician network with their patients receipt of and transitions between risky drug combinations

Crossref DOI link: https://doi.org/10.1007/s41109-025-00721-y

Published Online: 2025-07-21

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

O’Malley, A. James

Meara, Ellen

Morden, Nancy E.

Moen, Erika L.

Ran, Xin
Funding

Funding for this research was provided by:

National Institutes of Health (NIH), United States (P01 AG019783, P01 AG019783, P01 AG019783, P01 AG019783, P01 AG019783)
License Information

Text and Data Mining valid from 2025-07-21

Version of Record valid from 2025-07-21
More Information

Article History

Received: 23 February 2025

Accepted: 18 June 2025

First Online: 21 July 2025

Declarations

:

: The authors declare that there are no competing interests.

Document is current

Any future updates will be listed below